Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Covington
Fish and Richardson
Julphar
Colorcon
Express Scripts
AstraZeneca
McKesson
Cantor Fitzgerald
Johnson and Johnson

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,352,717

« Back to Dashboard

Which drugs does patent 6,352,717 protect, and when does it expire?

Patent 6,352,717 protects FORTOVASE and is included in one NDA.

Protection for FORTOVASE has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has thirty-seven patent family members in thirty-four countries.
Summary for Patent: 6,352,717
Title: Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses
Abstract:The present invention provides a process for encapsulating a shear sensitive fill mass which contains a pharmaceutical active agent or nutrient, characterized in that said fill mass is heated and subsequently cooled, prior to the encapsulation. The invention also provides capsules comprising shear sensitive fill material obtained by the said process which have a high and constant dissolution rate.
Inventor(s): Alex; Rainer (Weil am Rhein, DE), Gerhards; Jurgen (Arlesheim, CH), Kraemer-Pittrof; Ingeborg (Rheinfelden, DE), Oeschger; Richard (Rheinsulz, CH), Rades; Thomas (Dunedin, NZ)
Assignee: Hoffman-La Roche Inc. (Nutley, NJ)
Application Number:09/440,731
Patent Claim Types:
see list of patent claims
Dosage form; Process; Formulation;

Drugs Protected by US Patent 6,352,717

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Hoffmann La Roche FORTOVASE saquinavir CAPSULE;ORAL 020828-001 Nov 7, 1997 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,352,717

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
98121831Nov 17, 1998

International Patents Family Members for US Patent 6,352,717

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 020013 ➤ Try a Free Trial
Austria 274895 ➤ Try a Free Trial
Australia 1775100 ➤ Try a Free Trial
Australia 751446 ➤ Try a Free Trial
Brazil 9915444 ➤ Try a Free Trial
Canada 2350943 ➤ Try a Free Trial
China 1172649 ➤ Try a Free Trial
China 1326335 ➤ Try a Free Trial
Colombia 5150161 ➤ Try a Free Trial
Czech Republic 20011644 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Argus Health
UBS
AstraZeneca
QuintilesIMS
McKinsey
Citi
Chubb
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot